While the most commonly reported effect of HDAC inhibitors on tumor cells is as an inducer of apoptosis, they have also been shown to interfere with cellular growth [1–3] and differentiation [2, 4] and to inhibit angiogenesis [5, 6]. The gene discussed is HDAC9; the disease is neoplasm.